{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:02:43Z","timestamp":1789581763908,"version":"build-2803163510"},"reference-count":185,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tumor progression is driven by metabolic remodeling that generates a microenvironment characterized by nutrient deprivation, hypoxia, lactate accumulation, lipid dysregulation, and oxidative stress. These conditions affect innate immune populations, including natural killer (NK) cells, dendritic cells (DCs), macrophages, neutrophils, and myeloid-derived suppressor cells (MDSCs), shaping their activation, persistence, and functional states. Although many studies have defined metabolic pathways that regulate innate immune function in cancer, these findings are often discussed at the level of individual pathways or individual cell types, obscuring shared principles by which the tumor microenvironment controls innate immunity. Here, we use the concepts of metabolic licensing and metabolic restriction to describe how metabolic capacity and environmental constraints interact to shape innate immune function. Metabolic licensing refers to context-dependent metabolic states that provide sufficient bioenergetic and biosynthetic capacity to support sustained antitumor effector function, whereas metabolic restriction describes conditions in which nutrient limitation, mitochondrial dysfunction, redox imbalance, or suppressive metabolites constrain or progressively erode these functions. Rather than representing fixed binary states, licensing and restriction can occur along a continuum shaped by cell identity, signal duration, and local tumor conditions. We discuss how metabolic licensing and restriction shape antitumor and immunosuppressive innate immune populations, examine the stress-sensing pathways that connect environmental cues to innate immune fate, and summarize therapeutic strategies aimed at restoring metabolic fitness or alleviating metabolic restriction. Considering innate immune responses in terms of metabolic licensing and restriction helps explain how shared metabolic pressures within tumors can impair effector cells while supporting suppressive innate populations and may inform the development of immunometabolic approaches to cancer therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1935435","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:21:09Z","timestamp":1789579269000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic licensing and restriction of innate immunity in the tumor microenvironment"],"prefix":"10.3389","volume":"17","author":[{"given":"Ji Min","family":"Shin","sequence":"first","affiliation":[{"name":"Department of Life Science, Ewha Womans University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Yeon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Life Science, Ewha Womans University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyoun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Life Science, Ewha Womans University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Ah","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Life Science, Ewha Womans University","place":["Seoul, Republic of Korea"]},{"name":"Research Center for Cellular Homeostasis, Ewha Womans University","place":["Seoul, Republic of Korea"]},{"name":"Multitasking Macrophage Research Center, Ewha Womans University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e13","article-title":"Regulatory t cell metabolism: a promising therapeutic target for cancer treatment","volume":"25","author":"Kim","year":"2025","journal-title":"Immune Netw"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-0617","article-title":"Microenvironmental metabolism regulates antitumor immunity","volume":"79","author":"Ngwa","year":"2019","journal-title":"Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5483\/bmbrep.2024-0031","article-title":"Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy","volume":"57","author":"Lim","year":"2024","journal-title":"BMB Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-026-01759-3","article-title":"Metabolic reprogramming of myeloid cells in cancer: from lactate-NAMPT axis to AI-guided therapeutics","volume":"58","author":"Lee","year":"2026","journal-title":"Exp Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-026-01411-0","article-title":"Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment","volume":"23","author":"Du","year":"2026","journal-title":"Cell Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-026-00622-4","article-title":"Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy","volume":"15","author":"Fenouille","year":"2026","journal-title":"Oncogenesis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1038\/s41467-022-32849-1","article-title":"Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells","volume":"13","author":"Adamik","year":"2022","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040904","article-title":"Metabolism of innate immune cells in cancer","volume":"13","author":"Talty","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41573-024-01098-w","article-title":"Targeting metabolic dysfunction of CD8 t cells and natural killer cells in cancer","volume":"24","author":"Viel","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41419-025-08180-0","article-title":"The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy","volume":"16","author":"Xie","year":"2025","journal-title":"Cell Death Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41568-025-00836-5","article-title":"Endoplasmic reticulum stress responses in anticancer immunity","volume":"25","author":"Hwang","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-026-01713-3","article-title":"Metabolic adaptations of immunosuppressive cells in cancer: mechanisms and therapeutic targets","volume":"58","author":"Kim","year":"2026","journal-title":"Exp Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120236","article-title":"Metabolic regulation of immune responses","volume":"32","author":"Ganeshan","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-030518-055817","article-title":"Immunometabolism in the tumor microenvironment","volume":"5","author":"Roy","year":"2021","journal-title":"Annu Rev Canc Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.115.305551","article-title":"HIF-1alpha and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages","volume":"35","author":"Tawakol","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1180488","article-title":"Rapid glycolytic activation accompanying innate immune responses: mechanisms and function","volume":"14","author":"Namgaladze","year":"2023","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-026-04999-x","article-title":"Targeting glutamine metabolism to modulate macrophage functions in the tumor microenvironment","volume":"17","author":"Wu","year":"2026","journal-title":"Discov Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-08210-1","article-title":"Metabolic pattern changes of macrophages during cancer development and progression","volume":"24","author":"Liu","year":"2026","journal-title":"J Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-6719524\/v1","article-title":"Transcriptional states of lung cancer microenvironment reveal macrophage subtype dynamics linked to disease progression","volume":"214","author":"Keremitci","year":"2025","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41419-020-03175-5","article-title":"Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy","volume":"11","author":"Cerezo","year":"2020","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2026.108194","article-title":"Metabolic control of immunity and inflammation: mitochondrial dynamics, pharmacological targets, and therapeutic opportunities","volume":"227","author":"Wang","year":"2026","journal-title":"Pharmacol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00287","article-title":"Regulations of glycolytic activities on macrophages functions in tumor and infectious inflammation","volume":"10","author":"Yu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Marcais","year":"2014","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104859","article-title":"Metabolic reprogramming of NK cells drives anti-tumor immunity","volume":"215","author":"Yang","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117035","article-title":"Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors","volume":"45","author":"Wang","year":"2026","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109210","article-title":"Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function","volume":"35","author":"Sheppard","year":"2021","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.06.047","article-title":"Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells","volume":"143","author":"Schafer","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2467","article-title":"Re(de)fining the dendritic cell lineage","volume":"13","author":"Satpathy","year":"2012","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140749","article-title":"Metabolic regulation of dendritic cell activation and immune function during inflammation","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation","volume":"15","author":"Everts","year":"2014","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1038\/s41467-018-04804-6","article-title":"Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration","volume":"9","author":"Guak","year":"2018","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/jci166031","article-title":"Glycolysis drives STING signaling to facilitate dendritic cell antitumor function","volume":"133","author":"Hu","year":"2023","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840029","article-title":"Metabolic reprogramming induces macrophage polarization in the tumor microenvironment","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01383","article-title":"Toll-like receptor ligands and interferon-gamma synergize for induction of antitumor M1 macrophages","volume":"8","author":"Muller","year":"2017","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","article-title":"Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) t cell infiltration","volume":"44","author":"Wang","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110171","article-title":"Macrophages are metabolically heterogeneous within the tumor microenvironment","volume":"37","author":"Geeraerts","year":"2021","journal-title":"Cell Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.115073","article-title":"Glycolysis drives STING signaling to promote M1-macrophage polarization and aggravate liver fibrosis","volume":"21","author":"Chen","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12964-024-01828-y","article-title":"CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0453-7","article-title":"Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses","volume":"20","author":"Langston","year":"2019","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115618","article-title":"STING activation in macrophages by vanillic acid exhibits antineoplastic potential","volume":"213","author":"Zhu","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.736882","article-title":"Pseudomonas aeruginosa PcrV enhances the nitric oxide-mediated tumoricidal activity of tumor-associated macrophages via a TLR4\/PI3K\/AKT\/mTOR-glycolysis-nitric oxide circuit","volume":"11","author":"Yu","year":"2021","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1453886","article-title":"Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy","volume":"15","author":"Ahn","year":"2024","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00202","article-title":"Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"14916","DOI":"10.1038\/s41598-019-51287-6","article-title":"Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells","volume":"9","author":"Ojo","year":"2019","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molmed.2025.04.004","article-title":"Powering immunity: mitochondrial dynamics in natural killer cells","volume":"32","author":"Verhezen","year":"2026","journal-title":"Trends Mol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002044","article-title":"TGFbeta drives NK cell metabolic dysfunction in human metastatic breast cancer","volume":"9","author":"Slattery","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0511-1","article-title":"Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-026-02786-3","article-title":"Mitochondrial preservation through the PKA-DRP1 axis empowers natural killer cells to resist acidic stress and retain cytotoxicity","volume":"24","author":"Maeng","year":"2026","journal-title":"Cell Commun Signal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101454","article-title":"Conditional deletion of PGC-1alpha results in energetic and functional defects in NK cells","volume":"23","author":"Gerbec","year":"2020","journal-title":"iScience"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s560635","article-title":"The role of mitochondrial regulation in macrophage polarization: Implications for the pathogenesis of rheumatoid arthritis","volume":"18","author":"Li","year":"2025","journal-title":"J Inflammation Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41467-017-01919-0","article-title":"Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability","volume":"8","author":"Gao","year":"2017","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.01.075","article-title":"Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation","volume":"355","author":"Zhao","year":"2023","journal-title":"J Control Release"},{"key":"B56","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41418-022-01076-y","article-title":"OPA1 drives macrophage metabolism and functional commitment via p65 signaling","volume":"30","author":"Sanchez-Rodriguez","year":"2023","journal-title":"Cell Death Differ"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2025.11.01.686039","DOI":"10.1101\/2025.11.01.686039","article-title":"Mitochondrial dysfunction rewires macrophage metabolism, driving pro-inflammatory priming and immune system remodeling","author":"Markov","year":"2025","journal-title":"bioRxiv"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/science.adv6582","article-title":"Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity","volume":"392","author":"You","year":"2026","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1251643","article-title":"Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","article-title":"Amino acid metabolism in immune cells: Essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy","volume":"16","author":"Yang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18091474","article-title":"Amino acid-driven mitochondrial metabolic rewiring controls antitumor immunity","volume":"18","author":"Ham","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700497","article-title":"Cutting edge: IL-2-induced expression of the amino acid transporters SLC1A5 and CD98 is a prerequisite for NKG2D-mediated activation of human NK cells","volume":"199","author":"Jensen","year":"2017","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-022-00909-0","article-title":"Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment","volume":"20","author":"Ma","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.131305","article-title":"Slc1a2-mediated glutamate transport promotes dendritic cell immunity through Sema3A-regulated cytoskeletal remodeling and migration","volume":"22","author":"Chen","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302339","article-title":"Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism","volume":"7","author":"Fernando","year":"2024","journal-title":"Life Sci Alliance"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiaf037","article-title":"Metabolic adaptations driving innate immune memory: Mechanisms and therapeutic implications","volume":"117","author":"Hao","year":"2025","journal-title":"J Leukoc Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2018.03.012","article-title":"Altered cellular metabolism drives trained immunity","volume":"29","author":"Sohrabi","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03155","article-title":"mTOR-dependent oxidative stress regulates oxLDL-induced trained innate immunity in human monocytes","volume":"9","author":"Sohrabi","year":"2018","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504784","article-title":"Covalent organic frameworks-delivered reuterin drives trained immunity in tumor-associated macrophages to enhance melanoma immunotherapy via glycerophospholipid metabolism","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70665","article-title":"Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment","volume":"16","author":"Wang","year":"2026","journal-title":"Clin Transl Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1172\/jci177606","article-title":"Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models","volume":"134","author":"Verma","year":"2024","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.10.007","article-title":"Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment","volume":"65","author":"Barron","year":"2016","journal-title":"Metabolism"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152752","article-title":"Characterization of glycolysis-related gene expression in Malignant melanoma","volume":"216","author":"Koch","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.13.6658","article-title":"c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth","volume":"94","author":"Shim","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m208011200","article-title":"c-Myc is required for the glucose-mediated induction of metabolic enzyme genes","volume":"278","author":"Collier","year":"2003","journal-title":"J Biol Chem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.c000023200","article-title":"Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc","volume":"275","author":"Osthus","year":"2000","journal-title":"J Biol Chem"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","article-title":"Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment","volume":"33","author":"Poznanski","year":"2021","journal-title":"Cell Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880959","article-title":"Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors","volume":"13","author":"Cohen","year":"2022","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0886-7","article-title":"Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy","volume":"123","author":"Cheung","year":"2020","journal-title":"Br J Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/metabo16010075","article-title":"Lactic acid in tumour biology","volume":"16","author":"Cruz","year":"2026","journal-title":"Metabolites"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-026-03063-5","article-title":"Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer","volume":"12","author":"Ielpo","year":"2026","journal-title":"Cell Death Discov"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-025-01570-0","article-title":"Histone lactylation in gastrointestinal cancers: Developing immunotherapeutic drugs targeting epigenetics","volume":"48","author":"Huang","year":"2025","journal-title":"Arch Pharm Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113688","article-title":"Histone lactylation inhibits RARgamma expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00124.2024","article-title":"Hypoxia conduces the glioma progression by inducing M2 macrophage polarization via elevating TNFSF9 level in a histone-lactylation-dependent manner","volume":"327","author":"Li","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12967-025-06235-6","article-title":"Metabolic interplay between endometrial cancer and tumor-associated macrophages: Lactate-induced M2 polarization enhances tumor progression","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41467-025-56392-x","article-title":"MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma","volume":"16","author":"Niveau","year":"2025","journal-title":"Nat Commun"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010094","article-title":"Hypoxia-induced reactive oxygen species: Their role in cancer resistance and emerging therapies to overcome it","volume":"14","author":"Mendoza","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/imr.13316","article-title":"Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment","volume":"323","author":"Moinuddin","year":"2024","journal-title":"Immunol Rev"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-014-1189-3","article-title":"Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1alpha-dependent and extracellular adenosine-mediated tumor protection","volume":"92","author":"Hatfield","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02533","article-title":"Adenosinergic signaling alters natural killer cell functional responses","volume":"9","author":"Chambers","year":"2018","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02358","article-title":"Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration","volume":"9","author":"Parodi","year":"2018","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00060","article-title":"Immunometabolic dysfunction of natural killer cells mediated by the hypoxia-CD73 axis in solid tumors","volume":"6","author":"Chambers","year":"2019","journal-title":"Front Mol Biosci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-11-2104","article-title":"Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide","volume":"71","author":"Barsoum","year":"2011","journal-title":"Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2026.2626181","article-title":"DRP1 depletion protects NK cells from hypoxia-induced dysfunction","volume":"31","author":"Verhezen","year":"2026","journal-title":"Redox Rep"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.70151","article-title":"A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications","volume":"19","author":"Hacker","year":"2025","journal-title":"Mol Oncol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-20-1023","article-title":"PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress","volume":"10","author":"Klopotowska","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn0164","article-title":"Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints","volume":"10","author":"Pouxvielh","year":"2024","journal-title":"Sci Adv"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/imm.70095","article-title":"Alterations in NK cell function and glucose metabolism characteristics in patients with progressive hepatocellular carcinoma","volume":"178","author":"Yu","year":"2026","journal-title":"Immunology"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.08.012","article-title":"Glycolytic stimulation is not a requirement for M2 macrophage differentiation","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.02.016","article-title":"Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression","volume":"29","author":"Goossens","year":"2019","journal-title":"Cell Metab"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1565993","article-title":"Lactate modulates the function of myeloid-derived suppressor cells via Ten-Eleven-Translocation-2-mediated demethylation of glucocorticoid-inducible kinase 1 in lung cancer model","volume":"13","author":"Chu","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461455","article-title":"Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.cir-15-0036","article-title":"Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.07.139","article-title":"L-glutamine is a key parameter in the immunosuppression phenomenon","volume":"425","author":"Hammami","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B119","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1038\/s41467-018-07505-2","article-title":"Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression","volume":"9","author":"Rice","year":"2018","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1584987","article-title":"Metabolic reprogramming of tumor-associated neutrophils in tumor treatment and therapeutic resistance","volume":"13","author":"Lin","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15355","article-title":"Glutamate blunts cell-killing effects of neutrophils in tumor microenvironment","volume":"113","author":"Xiong","year":"2022","journal-title":"Cancer Sci"},{"key":"B124","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2026.07.001","article-title":"Temporal control of macrophage pro-inflammatory phenotype by a biphasic HIF-1alpha regulatory program","volume":"86","author":"Davanzo","year":"2026","journal-title":"Mol Cell"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2110","article-title":"Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin","volume":"5","author":"Tripathi","year":"2014","journal-title":"Oncotarget"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100587","article-title":"HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1038\/s41598-021-84916-0","article-title":"STAT3 governs the HIF-1alpha response in IL-15 primed human NK cells","volume":"11","author":"Coulibaly","year":"2021","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.09.008","article-title":"Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis","volume":"24","author":"Wenes","year":"2016","journal-title":"Cell Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189765","article-title":"AMPK-mTOR signaling and cellular adaptations in hypoxia","volume":"22","author":"Chun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B133","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12967-023-04772-6","article-title":"The role of AMPK in macrophage metabolism, function and polarisation","volume":"21","author":"Cui","year":"2023","journal-title":"J Transl Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00902-0","article-title":"Redox regulation of the immune response","volume":"19","author":"Morris","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2019.12.018","article-title":"Scavenging reactive oxygen species selectively inhibits M2 macrophage polarization and their pro-tumorigenic function in part, via Stat3 suppression","volume":"147","author":"Griess","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B138","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41392-021-00761-7","article-title":"XBP1 regulates the protumoral function of tumor-associated macrophages in human colorectal cancer","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B139","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2022.100122","article-title":"The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy","volume":"14","author":"Chen","year":"2022","journal-title":"Med Drug Discov"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112285","article-title":"Immunotherapeutic implications of Toll-like receptors activation in tumor microenvironment","volume":"14","author":"Zheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"B142","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-022-02271-y","article-title":"Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4\/MyD88 pathway","volume":"41","author":"Andreuzzi","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2018.4","article-title":"TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy","volume":"15","author":"Huang","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020297","article-title":"Toll-like receptors from the perspective of cancer treatment","volume":"12","author":"Javaid","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.839460","article-title":"Homogeneous Polyporus polysaccharide inhibit bladder cancer by resetting tumor-associated macrophages toward M1 through NF-kappaB\/NLRP3 signaling","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"B148","doi-asserted-by":"publisher","first-page":"9029327","DOI":"10.1155\/2017\/9029327","article-title":"HIF1alpha-induced glycolysis metabolism is essential to the activation of inflammatory macrophages","volume":"2017","author":"Wang","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-698027","article-title":"IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells","volume":"128","author":"Mao","year":"2016","journal-title":"Blood"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.01.006","article-title":"Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells","volume":"153","author":"Uppendahl","year":"2019","journal-title":"Gynecol Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005047","article-title":"Cytokine-induced natural killer cell training is dependent on cellular metabolism and is defective in obesity","volume":"5","author":"Kedia-Mehta","year":"2021","journal-title":"Blood Adv"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96219","article-title":"Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect","volume":"3","author":"Felices","year":"2018","journal-title":"JCI Insight"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01388-8","article-title":"Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis","volume":"24","author":"Ding","year":"2023","journal-title":"Nat Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2024.09.004","article-title":"Interleukin-1beta induces trained innate immunity in human hematopoietic progenitor cells in vitro","volume":"19","author":"Flores-Gomez","year":"2024","journal-title":"Stem Cell Rep"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01358-8","article-title":"IL-1 family cytokines in inflammation and immunity","volume":"22","author":"Garlanda","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2026.05.005","article-title":"IRG1\/itaconate rewires macrophage and lung tumor metabolism through G6PD inhibition","volume":"38","author":"Mansouri","year":"2026","journal-title":"Cell Metab"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2021.06.005","article-title":"Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma","volume":"23","author":"Wu","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"B160","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s11658-023-00503-3","article-title":"Metabolite itaconate in host immunoregulation and defense","volume":"28","author":"Yang","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-019-00232-2","article-title":"Tumor-infiltrating immunosuppressive cells in cancer-cell plasticity, tumor progression and therapy response","volume":"12","author":"Lorenzo-Sanz","year":"2019","journal-title":"Cancer Microenviron"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00637","article-title":"2-Deoxy-d-Glucose treatment decreases anti-inflammatory M2 macrophage polarization in mice with tumor and allergic airway inflammation","volume":"8","author":"Zhao","year":"2017","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104286","article-title":"Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy","volume":"362","author":"Adeshakin","year":"2021","journal-title":"Cell Immunol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2003782","article-title":"Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of beta-oxidation","volume":"16","author":"Yao","year":"2018","journal-title":"PloS Biol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00262-021-02861-3","article-title":"Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment","volume":"70","author":"O'Brien","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2022.2131084","article-title":"Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers","volume":"11","author":"Tang","year":"2022","journal-title":"Oncoimmunology"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-13-1091","article-title":"Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport","volume":"13","author":"Bola","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.12.041","article-title":"Targeting the Warburg effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase\/2,6-bisphosphatase 3 (PFKFB3)","volume":"22","author":"Brooke","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15468","article-title":"Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation","volume":"113","author":"Du","year":"2022","journal-title":"Cancer Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-22-2263","article-title":"A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"B174","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-18-0107","article-title":"Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer","volume":"17","author":"Todenhofer","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403831","article-title":"Hypoxia-responsive prodrug of ATR inhibitor, AZD6738, selectively eradicates treatment-resistant cancer cells","volume":"11","author":"Barnieh","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.700407","article-title":"Targeting hypoxia: Hypoxia-activated prodrugs in cancer therapy","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-24-1409","article-title":"PLT012, a humanized CD36-blocking antibody, is effective for unleashing antitumor immunity against liver cancer and liver metastasis","volume":"15","author":"Tzeng","year":"2025","journal-title":"Cancer Discov"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235912","article-title":"Targeting metabolism to control immune responses in cancer and improve checkpoint blockade immunotherapy","volume":"13","author":"Luby","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat Commun"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-0980","article-title":"Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy","volume":"24","author":"Orillion","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006619","article-title":"CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas","volume":"136","author":"Gang","year":"2020","journal-title":"Blood"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.004","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000249","article-title":"First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours","volume":"3","author":"Naing","year":"2024","journal-title":"BMJ Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1935435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:21:11Z","timestamp":1789579271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1935435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":185,"alternative-id":["10.3389\/fimmu.2026.1935435"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1935435","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1935435"}}